August 2026
1. GOULD KL, Johson NP
   Quantitative PET coronary flow capacity and comprehensive management of chronic CAD: Lessons from the randomized CENTURY trial.
   Atherosclerosis. 2026;419:120831.
   

   >> Share

   
   
2. REVAIAH PC, Vengrenyuk Y, Santosh VK, Karki M, et al
   Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study.
   Atherosclerosis. 2026;419:120836.
   

   >> Share

   
   
3. WANG W, Sun Y, Chang K, Zheng Z, et al
   Therapeutic targets for atherosclerotic coronary artery disease: druggable genome-wide Mendelian randomization analysis.
   Atherosclerosis. 2026;419:120810.
   

   >> Share

   
   July 2026
4. KARNEWAR S, Nguyen TA, Ozawa K, Huang W, et al
   Inflammasome inhibition in myocardial infarction reduces early reperfusion injury and suppresses systemic plaque activation.
   Atherosclerosis. 2026;420:121848.
   

   >> Share

   
   
5. LIAO CC, Hu WC, Yang SF, Li JM, et al
   Genome-wide cross-trait analysis reveals immunogenetic pleiotropy between autoimmune diseases and myocardial infarction and prioritizes therapeutic targets.
   Atherosclerosis. 2026;420:121849.
   

   >> Share

   
   June 2026
6. KERNISS H, Olbrich H, Curman P, Stander S, et al
   Pyoderma gangrenosum is associated with excess incident major atherothrombotic events.
   Atherosclerosis. 2026;418:120801.
   

   >> Share

   
   
7. CENKO E, Yoon J, Bergami M, Vasiljevic Z, et al
   Standard modifiable cardiovascular risk factors and acute coronary syndrome free survival.
   Atherosclerosis. 2026;417:120616.
   

   >> Share

   
   
8. BICCIRE FG, Arbustini E, Ozaki Y, Fabbiocchi F, et al
   Long-term prognostic impact of optical coherence tomography detected plaque rupture in nonculprit coronary segments.
   Atherosclerosis. 2026;417:120681.
   

   >> Share

   
   
9. MATUTE-BLANCO L, Benitez ID, Belmonte T, Casanova-Sandoval J, et al
   Coronary macrovascular and microvascular involvement and their association with distinct circulating microRNA patterns: The ANFIBIO Study.
   Atherosclerosis. 2026;417:120778.
   

   >> Share

   
   
10. SCHUNKERT H
    The interplay of genetics and modifiable risk in atherosclerosis.
    Atherosclerosis. 2026;417:120727.
    

    >> Share

    
    
11. NAGAMINE T, Usui E, Kanaji Y, Ueno H, et al
    Identification of near-infrared spectroscopy-defined lipid content within or adjacent to calcified coronary plaques using optical coherence tomography.
    Atherosclerosis. 2026;417:120786.
    

    >> Share

    
    
12. WADSTROM BN, Wulff AB, Pedersen KM, Nordestgaard BG, et al
    Inflammation may explain part of atherosclerotic cardiovascular disease risk conferred by elevated remnant lipoproteins: a cohort and Mendelian randomization study.
    Atherosclerosis. 2026;417:120772.
    

    >> Share

    
    
13. LITTMANN K, Eriksson Hogling D, Suhel M, Juhlin K, et al
    Lipoprotein(a) cascade screening in coronary artery disease.
    Atherosclerosis. 2026;417:120759.
    

    >> Share

    
    May 2026
14. FANG C, Cui L, Zhao J, Du Z, et al
    Long-term prognostic value of residual lipid burden in acute myocardial infarction.
    Atherosclerosis. 2026;418:120795.
    

    >> Share

    
    
15. ANDREASSEN RM, Melsom T, Lochen ML, Wilsgaard T, et al
    Urinary orosomucoid and the risk of cardiovascular events and all-cause mortality in the general population. The Tromso Study 2007-2021.
    Atherosclerosis. 2026;417:120776.
    

    >> Share

    
    
16. ARAI T, Sakai K, Mori H, Mizukami T, et al
    Association of the residual SYNTAX score on clinical outcomes in patients with acute coronary syndrome.
    Atherosclerosis. 2026;416:120689.
    

    >> Share

    
    April 2026
17. ADANE TD, Sedaghati-Khayat B, Trap L, Dagnaw AB, et al
    Polygenic risk scores reveal shared polygenic risk across five common cardiovascular diseases.
    Atherosclerosis. 2026;417:120763.
    

    >> Share

    
    
18. LI L, Malik R, Abrahamian C, von Scheidt M, et al
    Common and distinct genetic features of three atherosclerotic cardiovascular diseases.
    Atherosclerosis. 2026;416:120733.
    

    >> Share

    
    
19. YAVARI N, Wai KM, Alsoudi AF, Koo E, et al
    Xanthelasma and its association with developing major cardio-cerebrovascular events.
    Atherosclerosis. 2026;416:120647.
    

    >> Share

    
    
20. ZHOU J, Guo X, Gao W, Xia Y, et al
    Evolocumab in patients with multivessel coronary disease after acute myocardial infarction: A target trial emulation.
    Atherosclerosis. 2026;416:120732.
    

    >> Share

    
    
21. EMANUELE E, Barth JD
    The persistent challenge of medication adherence after myocardial infarction in the real-world: Why compliance keeps taking the hit.
    Atherosclerosis. 2026;415:120695.
    

    >> Share

    
    
22. HALMOS B, Salzbrunn JB, van Zeventer IA, de Graaf AO, et al
    DNMT3A clonal hematopoiesis is associated with cardiovascular disease in women.
    Atherosclerosis. 2026;415:120722.
    

    >> Share

    
    
23. KATAOKA Y, Nicholls SJ, Kitahara S, Katasako-Yabumoto A, et al
    Achieving LDL-C <1.0 mmol/L and cardiovascular outcomes in patients with coronary artery disease who received percutaneous coronary intervention.
    Atherosclerosis. 2026;415:120684.
    

    >> Share

    
    
24. OTERINO A, Fernandez Olmo R, Martin Toro M, Cordero A, et al
    Intensive lipid-lowering strategies and major cardiovascular events in patients aged >/=65 years: A meta-analysis of randomized trial subgroups.
    Atherosclerosis. 2026;415:120714.
    

    >> Share

    
    
25. SEBASTIAN SA, Bimal T, Ayyalu T, Vartak N, et al
    Association of Lp(a) with coronary plaque burden and high-risk plaque features: A meta-analysis of imaging studies.
    Atherosclerosis. 2026;415:120706.
    

    >> Share

    
    
26. BEDNAREK A, Serruys PW, Tsai TY, Gumiezna K, et al
    Impact of coronary artery disease patterns assessed with pullback pressure gradient on clinical outcomes: Meta-analysis.
    Atherosclerosis. 2026;415:120688.
    

    >> Share

    
    
27. KIM M, Lee HA, Kim J, Kang HT, et al
    Metabolic dysfunction-associated steatotic liver disease and incident coronary events with revascularization: A nationwide cohort study.
    Atherosclerosis. 2026;415:120698.
    

    >> Share

    
    
28. ZABEN KJ, Khalil AA
    Health literacy and quality of life after acute coronary syndrome: the mediating role of self-care in Palestine.
    Atherosclerosis. 2026;415:120671.
    

    >> Share

    
    
29. POON EKW, Shishikura D, Silver JD, Hatzikostas L, et al
    Haemodynamic and blood viscosity profiles of culprit vs. non-culprit coronary vessels: Insights from NIRS-IVUS and CFD analysis.
    Atherosclerosis. 2026;415:120690.
    

    >> Share

    
    
30. SELEME VB, da Silva Costa IBS, Pileggi B, de Barros Branco CE, et al
    Association of cancer on coronary atherosclerotic burden and plaque rupture: Insights from the BRAVADO study.
    Atherosclerosis. 2026;415:120683.
    

    >> Share

    
    
31. RUIDAS B, Michaud WA, Lindner SR, Tessier SN, et al
    Improving cardiac resilience to ischemia/reperfusion: The role of butyrate in mitochondrial and metabolic recovery.
    Atherosclerosis. 2026;415:120669.
    

    >> Share

    
    March 2026
32. DAGHLAS I, Georgakis MK, Brennan SO, Arsenault BJ, et al
    Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk.
    Atherosclerosis. 2026;415:120723.
    

    >> Share

    
    
33. SCHONCK WA, Hovingh GK, Blom DJ, Tromp T, et al
    Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry.
    Atherosclerosis. 2026;415:120717.
    

    >> Share

    
    
34. ODDEN MC, Liu X, Shah AM, Yang Y, et al
    Proteomic pathways mediating low socioeconomic status and cardiovascular events in older adults in CHS and ARIC.
    Atherosclerosis. 2026;415:120705.
    

    >> Share

    
    
35. MAVRIDIS A, Viktorisson A, Leosdottir M, Sunnerhagen KS, et al
    Medication adherence after myocardial infarction: Predictors, mortality and cardiovascular outcomes.
    Atherosclerosis. 2026;414:120664.
    

    >> Share

    
    
36. CHEN M, Ding N, Wang FM, Obisesan OH, et al
    Associations of cigarette smoking with coronary artery and extra-coronary calcification in older adults: The Atherosclerosis Risk in Communities study.
    Atherosclerosis. 2026;414:120673.
    

    >> Share

    
    
37. MUSHTAQ S, Al Rifai M, Pontone G, Al-Mallah MH, et al
    Imaging plaques or imaging fat.
    Atherosclerosis. 2026;414:120639.
    

    >> Share

    
    
38. BRIEGER DG, Gray MP, Fathieh S, Magnussen C, et al
    Coronary artery disease in the absence of standard modifiable risk factors (SMuRFs): The impact of sex.
    Atherosclerosis. 2026;414:120638.
    

    >> Share

    
    
39. UELAND T, Andersen GO, Varathalingam S, Khan Y, et al
    Circulating B-cell activating factor in acute coronary syndromes - association with adverse outcomes and progression of heart failure.
    Atherosclerosis. 2026;414:120642.
    

    >> Share

    
    
40. PATTI G, Grisafi L, Azzolina D, Cumitini L, et al
    Modifications of coronary plaque phenotype on lipid-lowering therapies and risk of cardiovascular events: a systematic review and meta-regression analysis.
    Atherosclerosis. 2026;414:120433.
    

    >> Share

    
    February 2026
41. HAENEL A, Jukema RA, Khoo JK, Coughlan F, et al
    The association of risk factors on coronary computed tomography angiography derived atherosclerotic plaque volume - Lessons from the ADVANCE registry.
    Atherosclerosis. 2026;413:120515.
    

    >> Share

    
    
42. MITSUI K, Kataoka Y, Nicholls SJ, Kiyoshige E, et al
    Lipidic contents within calcified plaques: Characteristics and response to LDL-C<55 mg/dL on multi-modality imaging.
    Atherosclerosis. 2026;413:120500.
    

    >> Share

    
    
43. SAKAI K, Shinke T, Ali Z, Mizukami T, et al
    Functional and morphological characterization of coronary atherosclerosis.
    Atherosclerosis. 2026;413:120632.
    

    >> Share

    
    
44. GRIFFIN F, Fridolfsson J, Arvidsson D, Ekblom-Bak E, et al
    Lower cardiorespiratory fitness is associated with coronary artery atherosclerosis in individuals with a zero CAC score - cross-sectional results from SCAPIS.
    Atherosclerosis. 2026;413:120550.
    

    >> Share

    
    January 2026
45. LI M, Tian D, Delafontaine P, Sukhanov S, et al
    Coronary atherosclerotic plaque composition and classification in hypercholesterolemic pigs.
    Atherosclerosis. 2026;413:120635.
    

    >> Share

    
    
46. JOHANSEN MO, Vedel-Krogh S, Nielsen SF, Afzal S, et al
    Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: Pros and cons.
    Atherosclerosis. 2026;412:120605.
    

    >> Share

    
    
47. UEKI Y, Kakizaki R, Otsuka T, Itagaki T, et al
    Effect of alirocumab on coronary plaque stratified by atherothrombotic risk.
    Atherosclerosis. 2026;412:120588.
    

    >> Share

    
    December 2025
48. WANG Z, Hu X, Wen J, Xie Y, et al
    Monocyte to high-density lipoprotein ratio and risk of incident stroke, myocardial infarction, and mortality: A large prospective cohort study.
    Atherosclerosis. 2025;413:120631.
    

    >> Share

    
    
49. NOVO G, Arcari L, Madaudo C, Greco A, et al
    Blood Cell Subtype patterns in Takotsubo Syndrome and acute coronary syndrome: analysis from the GEIST registry.
    Atherosclerosis. 2025;411:120571.
    

    >> Share

    
    
50. JAE SY, Cho DH, Kunutsor SK, Choi J, et al
    Sex differences in mortality associated with physical activity before and after acute coronary syndrome.
    Atherosclerosis. 2025;411:120559.
    

    >> Share

    
    
51. YANG D, Wang G
    Beyond quantity: The nonlinear association between HDL cholesterol and coronary atherosclerosis.
    Atherosclerosis. 2025;411:120561.
    

    >> Share

    
    November 2025
52. SCILLETTA S, Welsh P, Beazer JD, Di Pino A, et al
    Ethnic differences in HDL quantity, quality, and potential associations with coronary heart disease risk.
    Atherosclerosis. 2025;411:120565.
    

    >> Share

    
    
53. TONG E, Chen Y, Chen C, Zhang F, et al
    Global, regional and national burden of ischemic heart disease attributable to ambient fine particulate matter pollution from 1990 to 2021, with predictions to 2072: An analysis of the global burden of disease study 2021.
    Atherosclerosis. 2025;410:120498.
    

    >> Share

    
    
54. MESEGUER-HERNANDEZ A, Buendia-Santiago F, Andreu-Cayuelas JM, Merino-Romero J, et al
    Atherogenic responsibility of lipoprotein (a) and other apolipoprotein B-containing lipoproteins in acute coronary syndrome.
    Atherosclerosis. 2025;410:120544.
    

    >> Share

    
    
55. KALHOR P, Mahmoudi Hamidabad N, Hellou E, Nogami K, et al
    Association of monocyte-to-lymphocyte ratio with coronary endothelial dysfunction and cardiovascular events in patients with angina and nonobstructive coronary artery disease.
    Atherosclerosis. 2025;410:120539.
    

    >> Share

    
    
56. KUKU KO, Garcia-Garcia HM, Mintz GS, Shah P, et al
    Coronary lipid burden indices predict non-culprit major adverse cardiac events independently of novel LDL estimates: Insights from the LRP study.
    Atherosclerosis. 2025;410:120525.
    

    >> Share

    
    
57. LAUKKANEN JA, Pohjonen T, Kurl S, Kunutsor SK, et al
    Associations of high-density lipoprotein cholesterol levels with the presence and severity of coronary atherosclerosis.
    Atherosclerosis. 2025;410:118629.
    

    >> Share

    
    
58. LEGGET ME, Earle NJ, Poppe KK, Bradbury KE, et al
    Lipoprotein(a) concentrations and secondary outcomes following first-time acute coronary syndrome: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS).
    Atherosclerosis. 2025;410:120516.
    

    >> Share

    
    October 2025
59. GIZARD F, Mohamedi N
    Influence of a mitochondria-associated membranes (MAMs) linker protein on coronary calcification: Commentary on "GRP75 inhibition attenuates arterial calcification" by Heyn J et al. Atherosclerosis 2025.
    Atherosclerosis. 2025;409:120497.
    

    >> Share

    
    
60. XU Q, Jin C, Qin Z, Zhao P, et al
    Ambient temperature and coronary plaque rupture risk in STEMI: Insights from OCT analysis.
    Atherosclerosis. 2025;409:120510.
    

    >> Share

    
    
61. ARTHI SRI AS, Veeraraghavan VP, Patil S, Raj AT, et al
    Identification of salivary inflammatory non coding RNA biomarkers for coronary artery disease through epicardial adipose tissue gene network analysis.
    Atherosclerosis. 2025;409:120486.
    

    >> Share

    
    
62. ARNOLD N, Gossling A, Weimann J, Bay B, et al
    Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk.
    Atherosclerosis. 2025;409:120475.
    

    >> Share

    
    
63. SILBERNAGEL G, Higbie H, Meininger T, Lemen D, et al
    Associations of ANGPTL proteins and complexes with progression of coronary artery calcification and coronary events.
    Atherosclerosis. 2025;409:120485.
    

    >> Share

    
    
64. AHN WJ, Rha SW, Choi BG, Choi SY, et al
    Long-term clinical outcomes according to first responsive dose of acetylcholine in patients with coronary artery spasm.
    Atherosclerosis. 2025;409:120473.
    

    >> Share

    
    
65. ATALLAH M, Harb T, Nasrallah N, Jones SR, et al
    Oxidized phospholipid dynamics in the early post-infarction period: Effects of PCSK9 inhibition with evolocumab.
    Atherosclerosis. 2025;409:120469.
    

    >> Share

    
    
66. MANUBOLU VS, Kinninger A, Lakshmanan S, Dahal S, et al
    Ethnic differences in coronary plaque burden and characteristics: A matched CCTA cohort study of South Asians and non-Hispanic Whites.
    Atherosclerosis. 2025;409:120455.
    

    >> Share

    
    
67. OLIVA A, Shneyderman M, Gitto M, Sartori S, et al
    Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2025;410:120523.
    

    >> Share

    
    September 2025
68. RAMASAMY A, Sivananthan A, Mohammed A, Kumaran S M T, et al
    Implications of imaging modalities on coronary vessel reconstruction and computation of the local hemodynamic forces.
    Atherosclerosis. 2025;408:120423.
    

    >> Share

    
    
69. CEDERSTROM S, Wang Y, Lundman P, Alfredsson J, et al
    Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals - an observational cross-sectional study.
    Atherosclerosis. 2025;408:120457.
    

    >> Share

    
    August 2025
70. TSCHARRE M, Mutschlechner D, Huber K, Gremmel T, et al
    Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
    Atherosclerosis. 2025;409:120478.
    

    >> Share

    
    
71. CANDREVA A, Morbiducci U, Erriquez A, Rizzini ML, et al
    Enhanced coronary physiology assessment with endothelial shear stress predicts residual cardiovascular risk in older patients with myocardial infarction.
    Atherosclerosis. 2025;409:120476.
    

    >> Share

    
    
72. KITAHARA S, Kataoka Y, Nicholls SJ, Funabashi S, et al
    Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trial.
    Atherosclerosis. 2025;409:120470.
    

    >> Share

    
    
73. MUENDLEIN A, Leiherer A, Brandtner EM, Geiger K, et al
    Serum leucine-rich alpha-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patients.
    Atherosclerosis. 2025;407:120413.
    

    >> Share

    
    
74. ALDUJELI A, Tsai TY, Haq A, Puipaite K, et al
    Impact of severe COVID-19 infection on coronary microvascular dysfunction in ANOCA patients: A cross-sectional study.
    Atherosclerosis. 2025;407:120389.
    

    >> Share

    
    July 2025
75. TOFT-NIELSEN F, Emanuelsson F, Nordestgaard BG, Benn M, et al
    Clinical familial hypercholesterolemia, heart healthy dietary adherence, and cardiovascular risk.
    Atherosclerosis. 2025 Jul 24:120463. doi: 10.1016/j.atherosclerosis.2025.120463.
    

    >> Share

    
    
76. GALIMBERTI F, Olmastroni E, Casula M, Xie S, et al
    Contribution and interaction of polygenic predisposition and family history of coronary heart disease in predicting cardiovascular risk.
    Atherosclerosis. 2025;408:120451.
    

    >> Share

    
    
77. RIVERO-SANTANA B, Saldana-Garcia J, Jurado-Roman A, Cantolla-Pablo P, et al
    Early anti-inflammatory therapy in acute myocardial infarction: A network meta-analysis of timing-dependent effects in 23 randomized trials and 28,220 patients.
    Atherosclerosis. 2025;408:120443.
    

    >> Share

    
    
78. WHITE JB, Lin A, Montarello NJ, Bursill CA, et al
    Changes to the serum lipidome and their relation to coronary plaque in the first six months after acute myocardial infarction.
    Atherosclerosis. 2025;408:120421.
    

    >> Share

    
    
79. TADA H, Furukawa A, Kojima N, Usui S, et al
    Protein-truncating variants of the cholesteryl ester transfer protein gene and risk for coronary artery disease among patients with heterozygous familial hypercholesterolemia.
    Atherosclerosis. 2025;408:120417.
    

    >> Share

    
    June 2025
80. FROBERT O, Pedersen IB, Hjelholt AJ, Erikstrup C, et al
    The flu shot and cardiovascular Protection: Rethinking inflammation in ischemic heart disease.
    Atherosclerosis. 2025 Jun 13:120405. doi: 10.1016/j.atherosclerosis.2025.120405.
    

    >> Share

    
    
81. MAGNONI M, Andreini D, Andreotti F, Latini R, et al
    Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaques.
    Atherosclerosis. 2025;407:120410.
    

    >> Share

    
    
82. MYLONAS N, Nikolaou PE, Siokatas G, Kostopoulos IV, et al
    Empagliflozin restores cardiac metabolism and suppresses immune activation in acute myocardial infarction.
    Atherosclerosis. 2025;407:120404.
    

    >> Share

    
    
83. WU JY, Chang HY, Kao CL, Hung KC, et al
    Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study.
    Atherosclerosis. 2025;407:120390.
    

    >> Share

    
    
84. FUJIMOTO D, Kinoshita D, Suzuki K, Niida T, et al
    Coronary spotty calcification, compared with macro calcification, is associated with a higher level of vascular inflammation and plaque vulnerability in patients with stable angina.
    Atherosclerosis. 2025;405:119237.
    

    >> Share

    
    May 2025
85. ELIAS-LOPEZ D, Kobylecki CJ, Vedel-Krogh S, Doi T, et al
    Association of low-grade inflammation and elevated remnant cholesterol with risk of ASCVD and mortality in impaired renal function.
    Atherosclerosis. 2025;406:119241.
    

    >> Share

    
    
86. SUZUKI T, Haberlen S, Peterson TE, Palella F, et al
    Coronary artery calcium and all-cause mortality in the Multicenter AIDS Cohort Study.
    Atherosclerosis. 2025;404:119181.
    

    >> Share

    
    
87. CONTE E, Lee SE, Chang HJ, Hadamitzky M, et al
    Sex related coronary plaque progression patterns among patients with family history as the sole cardiovascular risk factor: A PARADIGM sub-study.
    Atherosclerosis. 2025;404:119184.
    

    >> Share

    
    April 2025
88. SANTOS RD, Ray KK, De Bacquer D, Jennings C, et al
    Frequency of residual combined dyslipidemia and hypertriglyceridemia in patients with coronary heart disease in 13 countries across 6 WHO Regions: Results from INTERASPIRE.
    Atherosclerosis. 2025;405:119215.
    

    >> Share

    
    
89. TADA H, Nohara A, Usui S, Sakata K, et al
    Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia.
    Atherosclerosis. 2025;404:119185.
    

    >> Share

    
    
90. FAROOQ S, Generoso G, Bensenor IM, Santos RD, et al
    Low-density lipoprotein-cholesterol subfractions as predictors for coronary artery calcium incidence and progression - The Brazilian longitudinal study of Adult Health (ELSA - Brasil).
    Atherosclerosis. 2025;403:119171.
    

    >> Share

    
    
91. PIVORIUNAS J, Engebretsen I, Vethe NT, Kristiansen O, et al
    Statin adherence in coronary outpatients: The relationship between a novel blood test and pharmacy registry data.
    Atherosclerosis. 2025;403:119138.
    

    >> Share

    
    
92. YUAN X, Zhang L, Li X, Chen K, et al
    Differential lipid impact on mortality in patients undergoing CABG versus PCI.
    Atherosclerosis. 2025;403:119141.
    

    >> Share

    
    
93. FUJINO M, Di Giovanni G, Butters Bhsc J, Kataoka Y, et al
    Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS.
    Atherosclerosis. 2025;403:119145.
    

    >> Share

    
    
94. ZHANG P, Wang W, Xu Q, Cui J, et al
    Genetic association of circulating lipids and lipid-lowering drug targets with vascular calcification.
    Atherosclerosis. 2025;403:119136.
    

    >> Share

    
    March 2025
95. RIKHI R, Haidar A, Bhatia HS, Beam K, et al
    Association of lipoprotein(a) and diabetes in primary prevention of coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2025;404:119179.
    

    >> Share

    
    
96. SADLER M, Cannata A, Mackie S, Mondi Anandhakrishna R, et al
    Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction.
    Atherosclerosis. 2025;403:119169.
    

    >> Share

    
    
97. MOK Y, Ballew SH, Schrack JA, Howard CM, et al
    Mid-life physical activity and calcification of coronary arteries, aorta, and cardiac valves in late life: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2025;402:119115.
    

    >> Share

    
    
98. YABUMOTO N, Fujino M, Sugane H, Hosoda H, et al
    Clinical implications of calcification severity adjacent to calcified nodule: Its association with first and recurrent risks of target lesion revascularization after percutaneous coronary intervention.
    Atherosclerosis. 2025;402:119116.
    

    >> Share

    
    
99. ZHENG N, Liu Z, Ding Y, Wang X, et al
    Incremental prognostic value of pericoronary adipose tissue attenuation beyond conventional features in patients with nonobstructive coronary artery disease.
    Atherosclerosis. 2025;402:119075.
    

    >> Share

    
    February 2025
100. ZHANG Y, Wu J, Wang N, Zhu J, et al
     Global burden and national health inequity of ischemic heart disease attributed to kidney dysfunction from 1990 to 2021: Findings from the global burden of disease study 2021.
     Atherosclerosis. 2025 Feb 26:119140. doi: 10.1016/j.atherosclerosis.2025.119140.
     

     >> Share

     
     
101. KRUGER A, Willems van Dijk K, van Heemst D, Noordam R, et al
     Long-term body mass index trajectories and the risk of type 2 diabetes mellitus and atherosclerotic cardiovascular disease using healthcare data from UK Biobank participants.
     Atherosclerosis. 2025;403:119135.
     

     >> Share

     
     
102. CHIGNON A, Lettre G
     Using omics data and genome editing methods to decipher GWAS loci associated with coronary artery disease.
     Atherosclerosis. 2025;401:118621.
     

     >> Share

     
     
103. TUFARO V, Torii R, Aben JP, Parasa R, et al
     Can fast wall shear stress computation predict adverse cardiac events in patients with intermediate non-flow limiting stenoses?
     Atherosclerosis. 2025;401:119099.
     

     >> Share

     
     
104. YI B, He L, Zhang D, Zeng M, et al
     Non-culprit plaque healing on serial OCT imaging and future outcome in patients with acute coronary syndromes.
     Atherosclerosis. 2025;401:119092.
     

     >> Share

     
     
105. RAZIPOUR A, Grodecki K, Manral N, Geers J, et al
     AI-derived automated quantification of cardiac chambers and myocardium from non-contrast CT: Prediction of major adverse cardiovascular events in asymptomatic subjects.
     Atherosclerosis. 2025;401:119098.
     

     >> Share

     
     
106. GIBSON K, Forrest IS, Petrazzini BO, Duffy A, et al
     Evaluation of a machine learning-based metabolic marker for coronary artery disease in the UK Biobank.
     Atherosclerosis. 2025;401:119103.
     

     >> Share

     
     
107. MANIKPURAGE HD, Ricard J, Houessou U, Bourgault J, et al
     Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence.
     Atherosclerosis. 2025;401:119083.
     

     >> Share

     
     
108. DREXEL H, Mader A, Larcher B, Festa A, et al
     Remnant cholesterol and long-term incidence of death in coronary artery disease patients.
     Atherosclerosis. 2025;401:119048.
     

     >> Share

     
     January 2025
109. ARAUNA D, Chandia E, Nova-Lamperti E, Radojkovic C, et al
     Platelet Content from Acute Myocardial Infarction Patients: Elevated Levels of IL-6 and IL-8 and their impact on Endothelial Nitric Oxide Production.
     Atherosclerosis. 2025;403:119119.
     

     >> Share

     
     December 2024
110. WANDELL P, Li X, Carlsson AC, Sundquist J, et al
     Myocardial infarction in second-generation immigrants compared to native-born Swedes in the total population of Sweden.
     Atherosclerosis. 2024 Dec 26:119102. doi: 10.1016/j.atherosclerosis.2024.119102.
     

     >> Share

     
     
111. KYHL LK, Nordestgaard BG, Tybjaerg-Hansen A, Smith GD, et al
     VLDL triglycerides and cholesterol in non-alcoholic fatty liver disease and myocardial infarction.
     Atherosclerosis. 2024;401:119094.
     

     >> Share

     
     
112. JUHASZ V, Charlier FT, Zhao TX, Tsiantoulas D, et al
     Targeting the adaptive immune continuum in atherosclerosis and post-MI injury.
     Atherosclerosis. 2024;399:118616.
     

     >> Share

     
     
113. KATAOKA T, Morishita T, Uzui H, Sato Y, et al
     Very short-term effects of a single dose of a proprotein convertase subtilisin/kexin 9 inhibitor before percutaneous coronary intervention: A single-arm study.
     Atherosclerosis. 2024;399:118581.
     

     >> Share

     
     November 2024
114. MENG Q, Zhao L, Zhao N, An Y, et al
     Progression of coronary artery calcium density and major adverse cardiovascular events.
     Atherosclerosis. 2024;398:118593.
     

     >> Share

     
     
115. KLUNER LV, Chan K, Antoniades C
     Using artificial intelligence to study atherosclerosis from computed tomography imaging: A state-of-the-art review of the current literature.
     Atherosclerosis. 2024;398:117580.
     

     >> Share

     
     
116. LEIVA O, Zhou S, How J, Lee M, et al
     Readmission outcomes after acute coronary syndrome among patients with myeloproliferative neoplasms.
     Atherosclerosis. 2024;401:119046.
     

     >> Share

     
     October 2024
117. SIMONY SB, Langsted A, Mortensen MB, Nordestgaard BG, et al
     Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study.
     Atherosclerosis. 2024;399:118625.
     

     >> Share

     
     
118. HAGAN K, Mszar R, Cainzos-Achirica M, Blaha MJ, et al
     Low-density lipoprotein-cholesterol and subclinical coronary atherosclerosis in a middle-aged asymptomatic U.S. population: The Miami Heart Study at Baptist Health South Florida.
     Atherosclerosis. 2024;397:118551.
     

     >> Share

     
     
119. KILBO EDLUND K, Andersson EM, Asker C, Barregard L, et al
     Long-term ambient air pollution and coronary atherosclerosis: Results from the Swedish SCAPIS study.
     Atherosclerosis. 2024;397:117576.
     

     >> Share

     
     
120. GUGLIELMO M, Penso M, Carerj ML, Giacari CM, et al
     DEep LearnIng-based QuaNtification of epicardial adipose tissue predicts MACE in patients undergoing stress CMR.
     Atherosclerosis. 2024;397:117549.
     

     >> Share

     
     September 2024
121. ALDUJELI A, Tsai TY, Haq A, Tatarunas V, et al
     The association between trimethylamine N-oxide levels and coronary microvascular dysfunction and prognosis in patients with ST-elevation myocardial infarction.
     Atherosclerosis. 2024;398:118597.
     

     >> Share

     
     
122. VALLEJO-VAZ AJ, Dharmayat KI, Nzeakor N, Carrasco CP, et al
     Recurrent cardiovascular and limb events in 294,428 patients with coronary or peripheral artery disease or ischemic stroke on antiplatelet monotherapy: The RESRISK cohort study.
     Atherosclerosis. 2024;398:118589.
     

     >> Share

     
     
123. QIU J, Fu Y, Tian T, Mao Y, et al
     Suppression of FOXC1 induces pyroptosis of the coronary artery through activation of JAK2.
     Atherosclerosis. 2024;396:118543.
     

     >> Share

     
     August 2024
124. EYRICH TM, Dalila N, Christoffersen M, Tybjaerg-Hansen A, et al
     Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population.
     Atherosclerosis. 2024;397:118574.
     

     >> Share

     
     
125. VOLLEBERG RHJA, Mol JQ, Belkacemi A, Hermanides RS, et al
     Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction.
     Atherosclerosis. 2024;397:118568.
     

     >> Share

     
     
126. VAISAR T, Babenko I, Horvath KV, Niisuke K, et al
     Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease.
     Atherosclerosis. 2024;397:118565.
     

     >> Share

     
     
127. CHEN JX, Lu Q, Geng T, Wang Y, et al
     Differences in HDL-related coronary heart disease risk between individuals with and without diabetes.
     Atherosclerosis. 2024;397:118553.
     

     >> Share

     
     
128. TRAMUJAS L, Nogueira A, Felix N, de Barros E Silva PGM, et al
     Association of colchicine use with cardiovascular and limb events in peripheral artery disease: Insights from a retrospective cohort study.
     Atherosclerosis. 2024 Aug 9:118563. doi: 10.1016/j.atherosclerosis.2024.118563.
     

     >> Share

     
     
129. QI X, Zhang Y, Wang Y, Sun J, et al
     Prognostic value of serum immunoglobulin M levels in patients with acute coronary syndrome.
     Atherosclerosis. 2024;395:117552.
     

     >> Share

     
     
130. WENTZEL JJ, Bos D, White SJ, van der Heiden K, et al
     Sex-related differences in coronary and carotid vessel geometry, plaque composition and shear stress obtained from imaging.
     Atherosclerosis. 2024;395:117616.
     

     >> Share

     
     
131. PATEL NH, Dave EK, Fatade YA, De Cecco CN, et al
     Epicardial adipose tissue attenuation on computed tomography in women with coronary microvascular dysfunction: A pilot, hypothesis generating study.
     Atherosclerosis. 2024;395:118520.
     

     >> Share

     
     
132. MIRANDA MARAVI JS, Leszczynski EC, Schwartz CS, Dev PK, et al
     Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study.
     Atherosclerosis. 2024;395:117587.
     

     >> Share

     
     
133. ZHANG J, Zhong Q, Lin Y, Zhang Y, et al
     Longitudinal albuminuria patterns predict coronary artery calcification progression: Findings from the Coronary Artery Risk Development in Young Adults study.
     Atherosclerosis. 2024;395:117574.
     

     >> Share

     
     
134. FERRARO B
     The SR-B1DeltaCT/LDLR KO mouse: A new tool to shed light on coronary artery disease.
     Atherosclerosis. 2024;395:117564.
     

     >> Share

     
     
135. HOSHINO M, Jukema RA, Pijls N, Hoek R, et al
     Microvascular resistance reserve before and after PCI: A serial FFR and [(15)O] H(2)O PET study.
     Atherosclerosis. 2024;395:117555.
     

     >> Share

     
     
136. PARK CH, Kim HW, Park JT, Chang TI, et al
     Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study.
     Atherosclerosis. 2024;395:117563.
     

     >> Share

     
     
137. MULLIS DM, Padilla-Lopez A, Wang H, Zhu Y, et al
     Stromal cell-derived factor-1 alpha improves cardiac function in a novel diet-induced coronary atherosclerosis model, the SR-B1DeltaCT/LDLR KO mouse.
     Atherosclerosis. 2024;395:117518.
     

     >> Share

     
     
138. OLIVEIRA-SANTOS M, Borges-Rosa J, Silva R, Paixao L, et al
     Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT.
     Atherosclerosis. 2024;395:117481.
     

     >> Share

     
     July 2024
139. HUANG H, Liu J, Li Q, Qiao L, et al
     Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation.
     Atherosclerosis. 2024;394:117306.
     

     >> Share

     
     June 2024
140. BEN-SHABAT N, Krasun A, Fisher L, Patt YS, et al
     Anti-Ro and anti-La seropositivity is associated with increased rates of ischemic heart disease in adults: Results from a large population-based study.
     Atherosclerosis. 2024;396:117626.
     

     >> Share

     
     
141. IBRAHIM S, Hartgers ML, Reeskamp LF, Zuurbier L, et al
     LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia.
     Atherosclerosis. 2024 Jun 10:117610. doi: 10.1016/j.atherosclerosis.2024.117610.
     

     >> Share

     
     
142. GAGNON E, Bourgault J, Gobeil E, Theriault S, et al
     Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
     Atherosclerosis. 2024;393:117558.
     

     >> Share

     
     
143. GOUDA P, Islam S, Dover DC, Kaul P, et al
     Outcomes of management strategies in patients with prior coronary artery bypass grafting presenting with an acute coronary syndrome.
     Atherosclerosis. 2024;393:117477.
     

     >> Share

     
     
144. MASROURI S, Tamehri Zadeh SS, Shapiro MD, Khalili D, et al
     Impact of optimal cholesterol levels on subclinical atherosclerosis in the absence of risk factors in young adults.
     Atherosclerosis. 2024;393:117520.
     

     >> Share

     
     
145. WELSH RC, Gouda P, Dover D, Bainey KR, et al
     Applicability and impact of the COMPASS trial in a Canadian population of patients with atherosclerotic disease.
     Atherosclerosis. 2024;393:117486.
     

     >> Share

     
     May 2024
146. PINXTERHUIS TH, Ploumen EH, van Vliet D, Gert van Houwelingen K, et al
     Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.
     Atherosclerosis. 2024;392:117488.
     

     >> Share

     
     
147. JAIN V, Rifai MA, Kanaya AM, Shah NS, et al
     Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies.
     Atherosclerosis. 2024;392:117522.
     

     >> Share

     
     
148. SUGANE H, Asaumi Y, Ogata S, Kimura M, et al
     Evaluation of fractional flow reserve and atherosclerotic plaque characteristics on coronary non-contrast T1-weighted magnetic resonance imaging.
     Atherosclerosis. 2024;392:117530.
     

     >> Share

     
     
149. BERLOT AA, Fu X, Shea MK, Tracy R, et al
     Matrix Gla protein and the long-term incidence and progression of coronary artery and aortic calcification in the Multi-Ethnic Study of Atherosclerosis.
     Atherosclerosis. 2024;392:117505.
     

     >> Share

     
     
150. LARSSON J, Auscher S, Pararajasingam G, Heinsen LJ, et al
     Reply to: "Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition".
     Atherosclerosis. 2024;392:117524.
     

     >> Share

     
     
151. RAZAVI AC, Raggi P, Whelton SP
     Coronary artery calcium: The canary in the coal mine.
     Atherosclerosis. 2024;392:117499.
     

     >> Share

     
     
152. BUGIARDINI R, Gulati M
     Closing the sex gap in cardiovascular mortality by achieving both horizontal and vertical equity.
     Atherosclerosis. 2024;392:117500.
     

     >> Share

     
     
153. BERISHA-MUHARREMI V, Majnaric-Trtica L, Mujaj B
     Insulin resistance is an important index to assess glucose and insulin metabolism, but not a biological risk factor for high-risk coronary artery plaque composition.
     Atherosclerosis. 2024;392:117484.
     

     >> Share

     
     April 2024
154. ENGEBRETSEN I, Bugge C, Stovring H, Husebye E, et al
     Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event.
     Atherosclerosis. 2024;393:117550.
     

     >> Share

     
     
155. XIAO J, Wei H, Gao Z, Chen L, et al
     Differential age-specific associations of LDL cholesterol and body mass index with coronary heart disease.
     Atherosclerosis. 2024;393:117542.
     

     >> Share

     
     
156. GAGNON E, Arsenault BJ
     Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention.
     Atherosclerosis. 2024;391:117501.
     

     >> Share

     
     
157. HAN Y, Ren L, Fei X, Wang J, et al
     Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH).
     Atherosclerosis. 2024;391:117471.
     

     >> Share

     
     
158. RINALDI R, Colucci M, Torre I, Ausiello D, et al
     Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: The ABCD score.
     Atherosclerosis. 2024;391:117503.
     

     >> Share

     
     March 2024
159. MELNES T, Bogsrud MP, Christensen JJ, Rundblad A, et al
     Gene expression profiling in elderly patients with familial hypercholesterolemia with and without coronary heart disease.
     Atherosclerosis. 2024;392:117507.
     

     >> Share

     
     
160. ESCATE R, Padro T, Perez de Isla L, Fuentes F, et al
     Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients.
     Atherosclerosis. 2024;392:117502.
     

     >> Share

     
     
161. REXHAJ E, Bar S, Soria R, Ueki Y, et al
     Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
     Atherosclerosis. 2024;392:117504.
     

     >> Share

     
     
162. HAKAMAA E, Goebeler S, Martiskainen M, Louhelainen AM, et al
     Sex differences in coronary atherosclerosis during the pre- and postmenopausal period: The Tampere Sudden Death Study.
     Atherosclerosis. 2024;390:117459.
     

     >> Share

     
     
163. GRINBERG T, Eisen A, Talmor-Barkan Y, Kornowski R, et al
     Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort.
     Atherosclerosis. 2024;390:117469.
     

     >> Share

     
     
164. SCHLEGEL A
     Diagnostic challenge of an APOB variant of uncertain significance resolved by transheterozygosity with a pathological LDLR variant and clinical response to therapy.
     Atherosclerosis. 2024;390:117460.
     

     >> Share

     
     
165. CHEDID G, Malik A, Daher R, Welty FK, et al
     Reply to: "Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease"".
     Atherosclerosis. 2024;390:117452.
     

     >> Share

     
     
166. KHAN SU, Al-Mallah MH
     Air pollution and acute coronary syndrome: The air we breathe.
     Atherosclerosis. 2024;390:117453.
     

     >> Share

     
     
167. GU SZ, Ahmed ME, Huang Y, Hakim D, et al
     Comprehensive biomechanical and anatomical atherosclerotic plaque metrics predict major adverse cardiovascular events: A new tool for clinical decision making.
     Atherosclerosis. 2024;390:117449.
     

     >> Share

     
     
168. CENKO E, Manfrini O, Bugiardini R
     Net adverse clinical events with P2Y(12) inhibitor therapy in older patients after percutaneous coronary interventions.
     Atherosclerosis. 2024;390:117434.
     

     >> Share

     
     
169. ASMARIAN N, Raeisi Shahraki H
     Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease".
     Atherosclerosis. 2024;390:117426.
     

     >> Share

     
     
170. RINALDI R, Russo M, Bonanni A, Camilli M, et al
     Short-term air pollution exposure and mechanisms of plaque instability in acute coronary syndromes: An optical coherence tomography study.
     Atherosclerosis. 2024;390:117393.
     

     >> Share

     
     February 2024
171. OBISESAN OH, Boakye E, Wang FM, Dardari Z, et al
     Coronary artery calcium as a marker of healthy and unhealthy aging in adults aged 75 and older: The Atherosclerosis Risk in Communities (ARIC) study.
     Atherosclerosis. 2024 Feb 13:117475. doi: 10.1016/j.atherosclerosis.2024.117475.
     

     >> Share

     
     December 2023
172. FISHBEIN I, Inamdar VV, Alferiev IS, Bratinov G, et al
     Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the mitigating effect of stent surface modification with a CD47-derived peptide.
     Atherosclerosis. 2023;390:117432.
     

     >> Share

     
     
173. ZHANG D, Li P, Qiu M, Liang Z, et al
     Net clinical benefit of clopidogrel versus ticagrelor in elderly patients carrying CYP2C19 loss-of-function variants with acute coronary syndrome after percutaneous coronary intervention.
     Atherosclerosis. 2023 Dec 13:117395. doi: 10.1016/j.atherosclerosis.2023.117395.
     

     >> Share

     
     October 2023
174. AHMED AI, Saad JM, Alahdab F, Han Y, et al
     Prognostic value of positron emission tomography derived myocardial flow reserve: A systematic review and meta-analysis.
     Atherosclerosis. 2023;382:117280.
     

     >> Share

     
     September 2023
175. JONAS M, Genereux P, Maehara A, Ben-Yehuda O, et al
     Control of diabetes mellitus and the risk of neointimal hyperplasia after percutaneous coronary intervention: Post-hoc analysis from the BLADE-PCI trial.
     Atherosclerosis. 2023 Sep 3:117264. doi: 10.1016/j.atherosclerosis.2023.117264.
     

     >> Share

     
     August 2023
176. TIAN P, Liu Y, Wang J, Xing L, et al
     Correlation of neck circumference, coronary calcification severity and cardiovascular events in Chinese elderly patients with acute coronary syndromes.
     Atherosclerosis. 2023 Aug 18:117242. doi: 10.1016/j.atherosclerosis.2023.117242.
     

     >> Share

     
     July 2023
177. BARFOROSHI S, Manubolu VS, Wang R, McClelland RL, et al
     Incremental value of ABI and CAC beyond traditional risk markers in long-term prediction of cardiovascular disease incidence in participants with diabetes and impaired fasting glucose: Multi-Ethnic Study of Atherosclerosis.
     Atherosclerosis. 2023 Jul 6:117186. doi: 10.1016/j.atherosclerosis.2023.117186.
     

     >> Share

     
     June 2023
178. NIELSEN S, Nyvad J, Christensen KL, Poulsen PL, et al
     Obstructive sleep apnea, coronary calcification and arterial stiffness in patients with diabetic kidney disease.
     Atherosclerosis. 2023 Jun 29:117170. doi: 10.1016/j.atherosclerosis.2023.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share